Skip to content
March 28, 2024

Equity.Guru

Investment information for the new generation

Search

Orthobiologics

Ortho Regenerative Technologies (ORTH.C) got some bad news today in the form of a clinical hold letter from the FDA related to their investigational new drug (IND) application fo…
“2021 will be transformational for the company as we advance the clinical development of our lead product,” added LeDuc….